Stock Fundamentals

Company Information

Company Name
Neuropace Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US6412881053
CIK: 0001528287
CUSIP: 641288105
Currency: USD
Full Time Employees: 220
Phone: 650 237 2700
Fiscal Year End: December
IPO Date: Apr 22, 2021
Description:

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Address:

455 North Bernardo Avenue, Mountain View, CA, United States, 94043

Directors & Officers

Name Title Year Born
Mr. Joel D. Becker CEO, President & Director 1968
Mr. Patrick F. Williams Chief Financial Officer 1973
Dr. Martha J. Morrell M.D. Chief Medical Officer 1957
Ms. Rebecca L. Kuhn Advisor 1961
Mr. Dylan St. John Chief of Operations & Development NA
Mr. Scott R. Schaper Head of Investor Relations NA
Ms. Leah Akin General Counsel & Corporate Secretary NA
Ms. Katie Keller Vice President of Marketing NA
Mr. Chris Reese Senior Vice President of Sales NA
Ms. Amy Treadwell Vice President of Human Resources NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
May 14, 2025 Orbimed Advisors Llc N/A Sale 168.14K $15.85 $2.66M

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Polar Capital Holdings PLC 3.30M Mar 31, 2026 9.71% $0.15 14.58%
Soleus Capital Management, L.P. 2.93M Mar 31, 2026 8.64% $1.56 8.47%
Morgan Stanley - Brokerage Accounts 2.57M Mar 31, 2026 7.56% $0.00 0.75%
First Light Asset Management, LLC 2.46M Mar 31, 2026 7.25% $2.90 82.29%
BlackRock Inc 2.35M Mar 31, 2026 6.91% $0.00 -1.58%
Orbimed Advisors, LLC 2.10M Mar 31, 2026 6.18% $0.55 -12.87%
Vanguard Group Inc 1.48M Dec 31, 2025 4.37% $0.00 3.23%
Driehaus Capital Management LLC 1.45M Mar 31, 2026 4.28% $0.14 -3.95%
Deutsche Bank AG 932.09K Mar 31, 2026 2.75% $0.00 0.28%
Armistice Capital, LLC 692.00K Mar 31, 2026 2.04% $0.16 -12.63%
Geode Capital Management, LLC 618.12K Mar 31, 2026 1.82% $0.00 3.67%
FMR Inc 553.53K Mar 31, 2026 1.63% $0.00 -11.43%
State Street Corp 497.55K Mar 31, 2026 1.47% $0.00 11.09%
Silvercrest Asset Management Group LLC 360.07K Mar 31, 2026 1.06% $0.03 -9.22%
Northern Trust Corp 239.84K Mar 31, 2026 0.71% $0.00 3.48%
Essex Investment Management Company, LLC 217.74K Mar 31, 2026 0.64% $0.45 1.80%
Palumbo Wealth Management LLC 210.47K Mar 31, 2026 0.62% $0.68 -1.73%
Qube Research & Technologies 186.19K Mar 31, 2026 0.55% $0.00 -6.44%
Algert Global LLC 179.56K Mar 31, 2026 0.53% $0.04 3.83%
The Goldman Sachs Group Inc 175.36K Mar 31, 2026 0.52% $0.00 6.47%

Shares Statistics

Shares Outstanding: 34.09M
Shares Float: 23.31M
% Insiders: 398.80%
% Institutions: 9,626.80%
Short % Float: 2.07%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Polar Capital Healthcare Opports Inc 2.89M 8.51% ▲ 0.00% Apr 30, 2026
2 Vanguard Total Stock Mkt Idx Inv 827.57K 2.44% ▲ 0.00% Apr 30, 2026
3 Xtrackers MSCI World Swap ETF 1C 737.12K 2.17% ▼ 0.63% Dec 31, 2025
4 iShares Russell 2000 ETF 601.52K 1.77% ▲ 0.85% Apr 30, 2026
5 Heptagon Driehaus US Micro Cap Eq C$ Acc 449.42K 1.32% ▲ 1.98% Apr 30, 2026
6 Polar Capital Glb Healthcare Ord 409.82K 1.21% ▲ 0.00% Apr 30, 2026
7 Fidelity Small Cap Growth 361.86K 1.07% ▼ 7.10% Feb 28, 2026
8 Vanguard Institutional Extnd Mkt Idx Tr 274.70K 0.81% ▲ 2.57% Apr 30, 2026
9 Fidelity Small Cap Index 247.91K 0.73% ▲ 0.94% Feb 28, 2026
10 BlackRock Advantage Small Cap Core Instl 227.09K 0.67% ▲ 0.00% Apr 30, 2026

Valuation Metrics

Enterprise Value: $579.37M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $555.39M
EBITDA: $-16.51M
Book Value: $0.57
Earnings/Share: $-0.65
Profit Margin: -21.67%
Operating Margin: -25.23%
ROA (TTM): -10.02%
ROE (TTM): -111.38%
Revenue (TTM): $99.53M
Revenue/Share (TTM): $2.99
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -2.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 5.28x 3.21x 0.82x -2.19x -4.24x
2024-12-31 5.37x 7.66x 0.92x -2.46x -3.70x
2023-12-31 5.71x 2.84x 0.81x -3.19x -2.57x
2022-12-31 8.90x 1.56x 0.70x -5.42x -1.49x
2021-12-31 14.28x 0.68x 0.45x -3.20x -1.76x
2020-12-31 5.69x -0.36x 3.64x -1.14x -4.24x
2019-12-31 0.27x -0.49x 7.13x -2.32x -3.13x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about NPCE.US!